pancan.ai/Ask
what is known about trial:nct:NCT06128551
Understood asRecord NCT06128551View getStudy → table
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.